Mesoblast Limited (AU:MSB) has released an update.
Mesoblast Limited has announced an update on its Director Dr. Eric Rose’s interests, revealing that he has recently purchased 19,734 American Depositary Shares (ADS) at a total value of $151,207.83. Following this transaction, Dr. Rose now holds a total of 41,162 ADS and 4,330,765 options. This change in director’s interest comes ahead of the 2024 Annual General Meeting, where Dr. Rose may be issued an additional 5,039,814 ordinary shares, subject to shareholder approval.
For further insights into AU:MSB stock, check out TipRanks’ Stock Analysis page.
